Evaluation of treatment adherence in patients with Behçet’s disease: its relation to disease manifestations, patients’ beliefs about medications, and quality of life
- 26 October 2018
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (3) , 761-768
Abstract
Despite its importance, adherence to treatment has not been sufficiently studied in Behçet’s disease (BD). The aim of this study was to evaluate medication adherence in BD using the Compliance Questionnaire of Rheumatology (CQR) and factors potentially affecting it.Keywords
This publication has 36 references indexed in Scilit:
- The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteriaJournal of the European Academy of Dermatology and Venereology, 2013
- Compliance with treatment of rheumatoid arthritisRheumatology International, 2011
- Patient Medication Adherence: Measures in Daily PracticeOman Medical Journal, 2011
- Adherence Rates and Associations with Nonadherence in Patients with Rheumatoid Arthritis Using Disease Modifying Antirheumatic DrugsThe Journal of Rheumatology, 2009
- Depression, medication adherence, and service utilization in systemic lupus erythematosusArthritis Care & Research, 2009
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Medication adherence in rheumatoid arthritis: effects of psychosocial factorsPsychology, Health & Medicine, 2004
- Patients' beliefs about treatmentJournal of Psychosomatic Research, 1999
- Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitidesArthritis & Rheumatism, 1997
- The rand 36‐item health survey 1.0Health Economics, 1993